Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 135 articles:
HTML format
Text format



Single Articles


    August 2017
  1. JHAWAR S, Hathout L, Elshaikh MA, Beriwal S, et al
    Adjuvant Chemoradiation Therapy for Cervical Cancer and Effect of Timing and Duration on Treatment Outcome.
    Int J Radiat Oncol Biol Phys. 2017;98:1132-1141.
    PubMed     Text format     Abstract available


  2. KIM TH, Kim MH, Kim BJ, Park SI, et al
    Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:1124-1131.
    PubMed     Text format     Abstract available


    July 2017
  3. JOO J, Shin HJ, Park B, Park SY, et al
    Integration Pattern of Human Papillomavirus Is a Strong Prognostic Factor for Disease-Free Survival After Radiation Therapy in Cervical Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:654-661.
    PubMed     Text format     Abstract available


    May 2017
  4. BERIWAL S, Klopp A, Mell L
    Defining Prognostic Biomarkers and Optimal Adjuvant Treatment for Gynecologic Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:1-4.
    PubMed     Text format    


    April 2017
  5. BINGHAM B, Orton A, Boothe D, Stoddard G, et al
    Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
    Int J Radiat Oncol Biol Phys. 2017;97:1040-1050.
    PubMed     Text format     Abstract available


  6. RAMLOV A, Pedersen EM, Rohl L, Worm E, et al
    Risk Factors for Pelvic Insufficiency Fractures in Locally Advanced Cervical Cancer Following Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:1032-1039.
    PubMed     Text format     Abstract available


    March 2017
  7. NOTICEWALA SS, Li N, Williamson CW, Hoh CK, et al
    Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:797-805.
    PubMed     Text format     Abstract available


  8. MELL LK, Sirak I, Wei L, Tarnawski R, et al
    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).
    Int J Radiat Oncol Biol Phys. 2017;97:536-545.
    PubMed     Text format     Abstract available


    January 2017
  9. CONWAY JL, Connors JM, Tyldesley S, Savage KJ, et al
    Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2017;97:35-41.
    PubMed     Text format     Abstract available


  10. LI N, Carmona R, Sirak I, Kasaova L, et al
    Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:164-172.
    PubMed     Text format     Abstract available


  11. CHAPMAN BV, Gill BS, Viswanathan AN, Balasubramani GK, et al
    Adjuvant Radiation Therapy for Margin-Positive Vulvar Squamous Cell Carcinoma: Defining the Ideal Dose-Response Using the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2017;97:107-117.
    PubMed     Text format     Abstract available


    November 2016
  12. HO JC, Allen PK, Bhosale PR, Rauch GM, et al
    Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2016 Nov 17. pii: S0360-3016(16)33438.
    PubMed     Text format     Abstract available


  13. WILLIAMSON CW, Green G, Noticewala SS, Li N, et al
    Prospective Validation of a High Dimensional Shape Model for Organ Motion in Intact Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:801-807.
    PubMed     Text format     Abstract available


  14. SWANICK CW, Castle KO, Vedam S, Munsell MF, et al
    Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:793-800.
    PubMed     Text format     Abstract available


  15. MACCHIA G, Cilla S, Deodato F, Ianiro A, et al
    Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial.
    Int J Radiat Oncol Biol Phys. 2016;96:606-13.
    PubMed     Text format     Abstract available


    October 2016
  16. HAN DY, Safigholi H, Soliman A, Ravi A, et al
    Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
    Int J Radiat Oncol Biol Phys. 2016;96:440-8.
    PubMed     Text format     Abstract available


  17. HEIJKOOP ST, Westerveld H, Bijker N, Feije R, et al
    Optimal Patient Positioning (Prone Versus Supine) for VMAT in Gynecologic Cancer: A Dosimetric Study on the Effect of Different Margins.
    Int J Radiat Oncol Biol Phys. 2016;96:432-9.
    PubMed     Text format     Abstract available


  18. LI N, Noticewala SS, Williamson CW, Shen H, et al
    ATLAS-Based Active Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  19. GUTHIER CV, Damato AL, Viswanathan AN, Hesser J, et al
    A Fast Inverse Treatment Planning Strategy Facilitating Optimized Catheter Selection in Image Guided Interstitial High-Dose-Rate Gynecologic Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  20. ARISTOPHANOUS M, Cardenas CE, Ho JC, Lee JS, et al
    Development of a Radiomics-Based Survival Prediction Model for Cervical Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  21. BERHANE H, Gill BS, Bernard M, Olawaiye A, et al
    Outcomes of Stage II Endometrial Cancer: UPMC Cancer Center Experience.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  22. ONAL C, Guler OC, Akkus Yildirim B
    Prognostic Utility of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  23. WONG AT, Schwartz D, Safdieh J, Weiner JP, et al
    Utilization of Adjuvant Therapies and Their Impact on Survival for Women With Stage IIIc Endometrial Adenocarcinoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  24. MAQUILAN G, Thomas K, Zhou Z, Wang J, et al
    Clinical and PET Parameters as Prognostic Factors for Patients with Cervical Carcinoma: Clinical Implications of a Predictive Model Generated by a Support Vector Machine.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  25. SINGH R, Chopra S, Engineer R, Kannan S, et al
    Impact of Cumulative Radiation Doses to Vagina on Late Toxicity and Sexual Quality of Life in Patients Treated With Postoperative Adjuvant Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  26. VISWANATHAN AN, Winter K, Miller BE, Xiao Y, et al
    Updated 4-Year Results for NRG Oncology/RTOG 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  27. NICHOLS EM, Bentzen SM, Scartoni D, Giacomelli I, et al
    National Cancer Data Base Analysis of Uterine Carcinosarcoma (UC): Improvement in Survival With the Use of Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  28. TAKATOSHI T, Uchida N, Tanino T, Sakaguchi H, et al
    Apparent Diffusion Coefficients (ADCs) in Diffusion-Weighted 3.0 Tesla MR Imaging Is Useful in Predicting Therapeutic Response to Concurrent Chemoradiation Therapy in Patients With Uterine Cervical Cancer: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  29. HONG JC, Foote J, Broadwater G, Sosa J, et al
    Total Treatment Duration for Cervical Cancer: Is 55 Days Still the Goal in the Era of Concurrent Chemotherapy?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  30. HONG JH, Lin SM, Ku HY, Liu TW, et al
    The Influence of Hospital Volume on Disease Outcomes of Advanced Uterine Cervical Cancer Patients: A Nationwide Cohort Study of Taiwan.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  31. MELL LK, Saenz CC, Yashar CM, McHale MT, et al
    Phase 1 Trial of Bone Marrow Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Gemcitabine in Stage IB-IVA Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  32. RODIN D, Hanna TP, Burger E, Zubizarreta E, et al
    Global Access to Radiation Therapy for Cervical Cancer: The Cost of Inaction.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  33. MELL LK, Sirak I, Wei L, Tarnawski RR, et al
    Phase 2 Multicenter Clinical Trial of Bone Marrow-Sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin for Stage IB-IVA Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  34. YASHAR CM, Petersen IA, Bosch WR, Albuquerque KV, et al
    Computed Tomography Consensus Clinical Target Volume Contouring for Intensity Modulated Radiation Therapy in Intact Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  35. HUYNH MA, Catalano PJ, Chen YH, Marcus KJ, et al
    Significant Reduction in Breast Cancer Risk as Long-Term Hodgkin Lymphoma Survivors Reach Menopausal Age.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  36. NOMDEN C, de Leeuw AA, Tanderup K, Lindegaard JC, et al
    Nodal Failure After Chemoradiation and Magnetic Resonance Imaging Guided Adaptive BT in Cervical Cancer: A Subanalysis Within Embrace.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  37. XIE L
    Acute Hematologic Toxicity and Long-Term Treatment Outcome of Concurrent Chemoradiation Therapy With Weekly Cisplatin and Paclitaxel in Patients With FIGO Stage IB2-IIIb Intact Cervical Cancer: A Single-Center Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  38. XIE C, Jin X, Li L
    Phase 3 Randomized Trial of Comparing Chemoradiation Therapy Versus Radiation Therapy Alone in Lymph Node-Negative Patients With Early-Stage Cervical Cancer Following Radical Hysterectomy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  39. SHOJAEI M, Dumitru N, Chandrasekara S, Pinder J, et al
    The Importance of Localization and Immobilization in Treatment for Endometrial Cancer With High-Dose-Rate Brachytherapy Using Multilumen Cylinders.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  40. WU Q, Craciusnescu O, Liang B, Light K, et al
    A VMAT Quality Assurance Technique Based on EPID in Cine Mode for Large Field Gynecological Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  41. VERGALASOVA I, Light K, Chino JP, Craciunescu OI, et al
    Simultaneous Integrated Boost (SIB) for Treatment of Gynecological Malignancies: Intensity Modulated Radiation Therapy (IMRT) Versus Volumetric Modulated Arc Therapy (VMAT).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  42. XU M, Maity A, Kirk ML, Zhai H, et al
    Proton Therapy Reduces Normal Tissue Dose Compared to Intensity Modulated Radiation Therapy in Extended Field Pelvic Radiation Therapy for Gynecologic Malignancies.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  43. TSUJII K, Ueda Y, Isono M, Miyazaki M, et al
    Dosimetric Impact of Rotational Setup Errors for Cervical Cancer Patients With Postoperative Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  44. CHEN YJ, Tai HC, Chi CW, Chen YB, et al
    Autologous Fat Grafting into Rectovaginal Space Reduces Radiation Dose and Acute Injury to Rectum for Uterine Cervix-Targeted Radiation Therapy in Swine.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  45. FENG Z, Tao C, Yu G, Qin S, et al
    Comparison of the Biology Optimization and Physical Optimization for Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  46. SHIBA S, Wakatsuki M, Okonogi N, Kato S, et al
    Synergistic Action of Cisplatin and Carbon Ion Irradiation in Adenocarcinoma of the Uterine Cervix and HeLa Cell Line.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  47. EPPERLY M, Rigatti L, Li S, Wipf P, et al
    Small Molecule GS-Nitroxide Radiation Mitigator JP4-039/F14 Is Safe and Effective in Pregnant E13.5 Mice.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  48. GREENWALT JC, Kharod S, Dessaigne C, Morris CG, et al
    Establishing the Need for Pregnancy Testing Guidelines in Patients Undergoing Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  49. CHOI E, Michaels B, Harris K, Gupta N, et al
    High Prevalence of Sexual Dysfunction Among Gynecologic Cancer Patients Treated With Radiation Therapy: Role of Treatment Technique and Time.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  50. MELL LK, Sirak I, Wei L, Tarnawski RR, et al
    Longitudinal Assessment of Quality of Life Following Intensity Modulated Radiation Therapy for Cervical Cancer: Preliminary Analysis of the INTERTECC Phase 2 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  51. DATTA NR, Rogers S, Hutton B, Klingbiel D, et al
    Network Meta-Analysis in Locally Advanced Cervical Cancer: Evaluation of Outcomes With Chemoradiation Therapy or Thermoradiation Therapy Versus Radiation Therapy Alone.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  52. FIORENTINO A, Giaj Levra N, Ricchetti F, Fersino S, et al
    Weekly Cisplatin and Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  53. KAGAWA K, Tarutani K, Hashimoto T, Yabuta K, et al
    Nonmalignant Localized Ascites as a Late Response to Pelvic Irradiation for Uterine Cervix Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  54. CHAN KY, Benwell Q, Schneider K, Ang M, et al
    A Canadian Experience: Current State and Challenges of Magnetic Resonance--Guided Cervical Cancer Brachytherapy in Ontario.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  55. SHAHID N, Ashworth A, Ang M, D'Souza DP, et al
    Current Practice of External Beam Radiation Therapy and Brachytherapy for Management of Endometrial Cancer in Ontario, Canada.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  56. MESKO S, Kamrava M
    Early Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) for Oligometastatic Gynecological Malignancies.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  57. KIM J, Lee J, Lee KJ, Kim Y, et al
    Survival Outcome of Cervical Cancer Patients Staged With Magnetic Resonance Imaging.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  58. WASHINGTON I, Walston SA, Quick AM
    The Impact of Disparities on Prolonged Treatment Time for Patients Undergoing Definitive Chemoradiation for Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  59. DENUNZIO NJ, Bergsma DP, Milano MT
    Outcomes in Patients With Limited Metastases From Gynecologic Neoplasms Treated With Targeted Radiation Therapies.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  60. TCHELEBI L
    Practices in Management of Stage IB Grade III Endometrioid Cancer in the United States.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  61. GULYBAN A, Baiwir M, Nicolas S, Nguyen PV, et al
    Actual Delivered Dose for CTV and Bladder During External Beam Radiation Therapy of Locally Advanced Cervical Cancer: Deformable Dose Accumulation Quality Assurance and Results.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  62. KIM Y, Liu Y, Flynn RT, Wu X, et al
    Expected Clinical Outcome Improvement of Rotating-Shield Brachytherapy (RSBT) for Cervical Cancer: Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) Evaluations.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  63. KUO HC, Mehta KJ, Yaparpalvi R, Garg M, et al
    Can Intensity Modulated Proton Therapy (IMPT) Be an Alternative to Image Guided Brachytherapy (IGBT) for Locally Advanced Cervical Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  64. HAUCK CR, Wigant JM, Nandalur SR, Ye H, et al
    Lymph-Vascular Space Invasion as a Risk Factor for Local Recurrence in Endometrial Adenocarcinoma Stratified by Surgical Technique.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  65. STAHL JM, Damast S
    Small Vaginal Cylinder Size Predicts for Reduced Tolerance of Brachytherapy in Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  66. ROVIROSA A SR, Holub K, Ascaso C, Sanchez J, et al
    Comparison of 3 Short Brachytherapy Schedules After Postoperative External Beam Radiation Therapy in Endometrial Carcinoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  67. LOGIE N, Paulson K, Ghosh S, Murray B, et al
    Patterns of Recurrence Following "Minipelvis" Radiation Therapy for Pathological STAGE II Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  68. MCGUNIGAL M, Liu JT, Chadha M, Gupta V, et al
    Patterns of Care for Adjuvant Therapy in High-Intermediate-Risk Stage I Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  69. RAI B, Miriyala R, Ghoshal S, Ballari NR, et al
    Margins Around the Involved Pelvic Lymph Nodes for Planning Simultaneous Integrated Boost in Patients With Cervical Cancer Undergoing Pelvic Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  70. CHEN W, Bai P, Pan J, Zheng X, et al
    To Assess the Changes of Volume and Spatial Location of Target Area During Cone Beam Computed Tomography for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  71. DONOVAN E, Eiriksson L, Reade C, Kaur H, et al
    The Pathologic and Treatment Factors Associated With Recurrence in Stage IA Serous Adenocarcinoma of the Uterus.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  72. KAWASHIMA A, Isohashi F, Mabuchi S, Okubo H, et al
    Early Outcomes and Dose-Volume Analysis for Patients With Cervical Cancer Treated With Computed Tomography-Based Treatment Planning in Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  73. HOU WH, Schultheiss TE, Wong JY, Wakabayashi MT, et al
    Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  74. CHENG G, He M, Zhao H, Zhang N, et al
    Radical Hysterectomy With Adjuvant Radiation Therapy Versus Definitive Radiation Therapy for International Federation of Gynecology and Obstetrics Stage IIb Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  75. STEBER C, DeMasi J, Aryal P, Randall ME, et al
    Initial Results of Outpatient Permanent Syed-Neblett Interstitial Implants Using Cesium-131 for Gynecologic Malignancies.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  76. KHAROUTA MZ, Sen N, Liao Y, Bernard D, et al
    Quantifying Pelvic Sidewall Dose in Magnetic Resonance-Based Tandem and Ring Brachytherapy for Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  77. ALBEESH RM, Alfieri J, Mansure JJ, Turgeon GA, et al
    Outcomes of Adjuvant Therapy in Stage 3 Endometrial Cancer Confined to the Pelvis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  78. OGINO I, Kitagawa M, Watanabe S, Aoki S, et al
    Calcium Phosphate Cement Paste Injection as a Marker of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  79. ISOHASHI F, Mabuchi S, Yoshioka Y, Tamari K, et al
    Postoperative Whole-Pelvic Intensity Modulated Radiation Therapy in Surgically Treated Cervical Cancer Patients With Adverse Risk Factors.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  80. DANG Y, Li X, Liu S, Wei L, et al
    A Retrospective Study of 344 Patients With FIGO Stage IIB Cervical Carcinoma After Neoadjuvant Chemoradiation Therapy in Cervical Cancer: Pelvic Lymph Node Dissection Should Be Tailored.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  81. NOTICEWALA SS, Li N, Williamson CW, Hoh CK, et al
    Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  82. YOUN P, Angel CL, DuBeshter B, Thomas SG, et al
    Clinical Outcome After Adjuvant Vaginal Brachytherapy for Stage I-II Papillary Serous Clear Cell Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  83. OSBORN V, Schwartz D, Shao M, Lee A, et al
    Patterns of Care of Intensity Modulated Radiation Therapy Usage in Postoperative Management of Uterine Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  84. ORWAT K, Mendoza A, Young Pierce J, Cooper SL, et al
    Predictive Value of High-Risk Human Papillomavirus and Positron Emission Tomography/Computed Tomography for Local Control After Chemoradiation for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  85. KUROKAWA M, Iwai Y, Togasaki G, Kanazawa A, et al
    Postoperative Radiation Therapy for Cervical Cancer: Three-Dimensional Conformal Radiation Therapy (3DCRT) Versus Intensity Modulated Radiation Therapy (IMRT).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  86. TAGGAR A, Phan T, Traptow L, Banerjee RN, et al
    Cervical Cancer Brachytherapy in Canada: A Focus on Interstitial Brachytherapy Utilization.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  87. LEE JK, Mahan M, Khan N, Hanna R, et al
    Survival Outcomes in Women With International Federation of Gynecology and Obstetrics Stage IIIC2 Endometrial Carcinoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  88. SEKII S, Murakami N, Nakamura S, Kashihara T, et al
    Supplementary Bladder Reference Point of High-Dose-Rate Intracavitary Brachytherapy for Cervical Cancer: Feedback 3-Dimension to 2-Dimension.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  89. KHULLAR K, Sudhoff M, Elson JK, Herzog T, et al
    A Comparison of Dosimetric Parameters in PET-Based Active Bone Marrow Volume and Total Bone Volume in Prediction of Hematologic Toxicity in Cervical Cancer Patients Treated with Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  90. PHILLIPS JN, Yaparpalvi R, Mehta KJ, Kuo HC, et al
    An Analysis of the Effect of Intrafraction Organ Motion on Gynecological High-Dose-Rate Brachytherapy Treatment.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  91. WANG X, Wang P, Li J, Yuan K, et al
    Image Guided Radiation Therapy Boost in Combination With High-Dose-Rate Intracavitary Brachytherapy for the Treatment of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  92. SHARMA DN, Gandhi AK, Adhikari N
    Definitive Radiation Therapy of Locally Advanced Cervical Cancer Initially Treated With Palliative Hypofractionated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  93. BAZIRE L, Dautruche A, Kirova YM, Cao KI, et al
    Pelvic Insufficiency Fracture After Intensity Modulated Radiation Therapy for Gynecologic Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  94. SHI F, Wang T, Wang J, Su J, et al
    Application of CT-Guided Ad-P53 Intratumoral Injection for Recurrent and Metastatic Gynecologic Cancer Patients Who Received Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  95. SCHOLEY J, Kirk ML, McGuire SM, Teo BK, et al
    Sparing Active Bone Marrow for Gynecologic Cancer Patients Using FLT-PET/CT in PBS Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  96. NEMOTO MW, Ikeda Y, Ii N, Toita T, et al
    Multi-Institutional Comparative Study of MRI Technique in Cervical Cancer Image-Based Brachytherapy (IGBT): 3D MRI With High Sampling Efficiency Versus Conventional 2D Multiplanar MRI.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  97. CHENG JY, Huang EY, Hsu SN, Wang CJ, et al
    Simultaneous Integrated Boost (SIB) of the Parametrium and Cervix in Radiation Therapy for Cervical Cancer: A Dosimetric Study of a New Novel Approach.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  98. SONG Y, Chen X, Erickson BA, Li A, et al
    Improving Delineation of Gross Tumor Volume Using Magnetic Resonance Imaging for External Beam Radiation Therapy of Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  99. MAYADEV JS, Elshaikh MA, Christie A, Nagel C, et al
    Prognostic Significance of Nodal Location in Stage IIIC Endometrial Carcinoma: Implications for Optimal Adjuvant Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  100. TANAKA H, Kato A, Kawaguchi M, Yamaguchi T, et al
    Pelvic Insufficiency Fractures After Whole-Pelvic Irradiation for Uterine Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  101. LIN SM, Hong JH, Ku HY, Liu TW, et al
    The Prognostic Impact of Overall Treatment Time on Disease Outcomes of Uterine Cervical Cancer Patients: A Nationwide Cohort Study of Taiwan.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  102. BECKTA JM, Wan W, Quinn BA, Fields EC, et al
    Socioeconomic Disparities in Cervical Cancer Patients Presenting to a Tertiary Care Facility.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  103. WU CC, Yanagihara T, Wuu YR, Jani A, et al
    Rectal Balloon Use in Intensity Modulated Radiation Therapy Planning for Posthysterectomy Gynecological Malignancies Can Limit Rectal Dose and Toxicity as Well as Limit Vaginal Displacement.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  104. MOHINDRA P, Bentzen SM, Giacomelli I, Scartoni D, et al
    Adjuvant Whole-Pelvic Radiation Therapy (WPRT) for Endometrioid Adenocarcinoma (EA): 45 Gy or 50/50.4 Gy?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  105. MAHMOUD OM, Green WR, Gabel M, Gibbon D, et al
    Replicating Landoni's Study in the Era of Chemotherapy: Postoperative or Radical Concurrent Chemoradiation Therapy in Early-Stage Cervical Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  106. ODEI B, Boothe D, Gaffney DK
    Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  107. YUCE SARI S, Guler OC, Gultekin M, Onal C, et al
    Adjuvant Small Pelvic Radiation Therapy in Cervical Cancer Patients With Minor Risk Factors.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  108. AZEVEDO TL, Hess CB, Kamrava M, Tavares Guerreiro Fregnani JH, et al
    Predicting the Necessity of Adding Catheters to Intracavitary Brachytherapy for Women Undergoing Definitive Chemoradiation for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  109. MANLEY HJ, O'Donnell BP, Echeverria A, Hsieh G, et al
    Treatment Compliance With Radiation for Women treated for Cervical Cancer in a Safety Net Health System.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  110. PAUL AG, Miller SR 2nd, Nalichowski A, Abrams J, et al
    Dosimetric Evaluation of Point A and Volume-Based High-Dose-Rate Plans: A Single-Institution Study on Adaptive Brachytherapy Planning for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  111. NWACHUKWU CR, von Eyben R, Kidd EA
    Radiation Therapy Improves Disease-Specific Survival in High-Grade Stage II Uterine Cancer Patients and Brachytherapy Alone May Be Sufficient.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  112. RODRIGUES A, Nawrocki J, Light K, Chino JP, et al
    Evaluation of Dose-Volume Metrics of an 18F-FDG Positron Emission Tomography Adaptive Treatment Planning Protocol for Gynecological Malignancies.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  113. CHIN RI, Tran L, Thomas MA, Siegel B, et al
    Changes in Cervical Cancer FDG Uptake Heterogeneity After Chemoradiation: Association With Tumor Recurrence and Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  114. LESTER-COLL NH, Park HS, Rutter CE, Corso CD, et al
    Who Benefits From Chemoradiation in Locally Advanced Endometrial Cancer? An Analysis of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  115. ZHANG Y, Shi M, Wei LC, Li J, et al
    Safety and Short-Term Effect of Docetaxel and Cisplatin Chemotherapy Concurrent With Pelvic Radiation Therapy in Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  116. SASIDHARAN A, Mahantshetty UM, Engineer R, Chopra S, et al
    Outcome After First Relapse in Patients With Locally Advanced Cervical Cancer Treated With Radical Radio (Chemo) Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  117. WONG AT, Schwartz D, Lee A, Shao M, et al
    Utilization of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  118. OKONOGI N, Wakatsuki M, Kato S, Shiba S, et al
    Long-Term Outcomes of Carbon Ion Radiation Therapy for Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  119. ROBIN TP, Amini A, Behbakht K, Fisher CM, et al
    Brachytherapy Should Not be Omitted When Treating Locally Advanced Neuroendocrine Cervical Cancer with Definitive Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  120. MAHMOUD OM, Gabel M, Jhawar S, Gibbon D, et al
    How Important Is Chemotherapy Timing and Treatment Duration in the Adjuvant Management of Cervical Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  121. ACHARYA S, Grigsby PW
    Access to Health Care and Disparities in Cervical Cancer Diagnosis, Treatment, and Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  122. WILLIAMSON CW, Green G, Noticewala S, Li N, et al
    Prospective Validation of a High-Dimensional Shape Model for Organ Motion in Intact Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  123. MOHINDRA P, Bentzen SM, Scartoni D, Giacomelli I, et al
    Adjuvant Therapy for Locoregionally Advanced Endometrioid Adenocarcinoma (EA): Upfront Chemotherapy (UC) or Upfront Radiation Therapy (UR)?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  124. WANG CJ, Christie A, Folkert MR, Xie XJ, et al
    Omitting Radiation From Adjuvant Management of Stage III Endometrial Cancer Is Associated With Reduced Survival: An Analysis From The National Cancer Data Base (NCDB).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  125. KODIYAN J, Samstein R, Trichter S, Nedialkova L, et al
    Partial Length Vaginal Brachytherapy for Endometrial Carcinoma With High-Risk Features Is as Effective as Full Length With Reduced Toxicity.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  126. MAHMOUD OM, Gabel M, Gibbon D, Leiser A, et al
    Can Chemotherapy Boost the Survival Benefit of Adjuvant Radiation Therapy in Early-Stage Cervical Cancer With Intermediate Risk Factors: A Population-Based Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  127. MARTELLA A, Hong JC, Foote J, Havrilesky L, et al
    The Impact of Time to Treatment Initiation for Adjuvant Chemotherapy and Radiation Therapy in Stage III Endometrial Cancer: A National Cancer Data Base Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  128. BOOTHE D, Orton A, Odei B, Suneja G, et al
    Chemoradiation Versus Chemotherapy or Radiation Alone in Stage III Endometrial Cancer: Patterns of Care and Impact on Overall Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  129. MANTZ CA
    Stereotactic Body Radiation Therapy as a Boost Alternative for Nonmetastatic Cancer of the Cervix and Endometrium: Disease Control and Quality of Life Outcomes From a Phase 2 Trial at 3 Years' Minimum Follow-up.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


    September 2016
  130. YASHAR CM, Beriwal S, Klopp A, Mell L, et al
    Progress in Vulvar and Endometrial Cancers: Exploiting Anatomy and Biology and Improving Systemic Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96:1-5.
    PubMed     Text format    


    August 2016
  131. MAK KS, Smith AB, Eidelman A, Clayman R, et al
    Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Aug 24. pii: S0360-3016(16)33135.
    PubMed     Text format     Abstract available


    April 2016
  132. ZOLCIAK-SIWINSKA A, Gruszczynska E, Bijok M, Jonska-Gmyrek J, et al
    Computed Tomography-Planned High-Dose-Rate Brachytherapy for Treating Uterine Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Apr 24. pii: S0360-3016(16)30136.
    PubMed     Text format     Abstract available


  133. SUSKO M, Craciunescu O, Meltsner S, Yang Y, et al
    Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2016;94:1099-105.
    PubMed     Text format     Abstract available


    March 2016
  134. GROVER S, Harkenrider MM, Cho LP, Erickson B, et al
    Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy Society.
    Int J Radiat Oncol Biol Phys. 2016;94:598-604.
    PubMed     Text format     Abstract available


  135. POTTER R, Federico M, Sturdza A, Fotina I, et al
    Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2016;94:588-97.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: